Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of Kidney”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT06760702
What this trial is testing

A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AUR 109 in Patients With Colorectal, Ovarian, and Renal Cancers

Who this might be right for
Ovarian CancerColorectal CancerRenal Cancer
Aurigene Discovery Technologies Limited 29
Early research (Phase 1)Active Not RecruitingNCT06132945
What this trial is testing

Cabozantinib and Nivolumab With Radiation Therapy for People With Renal Cell Carcinoma That Has Spread to the Brain

Who this might be right for
Metastatic Renal Cell CarcinomaBrain Metastases
Memorial Sloan Kettering Cancer Center 2
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06574412
What this trial is testing

Cardenilimab Combined With Lenvatinib in Patients With Perioperative Resectable Clear Cell Renal Cell Carcinoma.

Who this might be right for
Resectable Clear Cell Carcinoma of the Kidney
The First Hospital of Jilin University 30
Not applicableUnknownNCT02734329
What this trial is testing

Zero Ischemia Laparoscopic Radio Frequency/Microwave Ablation Assisted Enucleation of Renal Cell Carcinoma With T1 Stage

Who this might be right for
Kidney Neoplasms
RenJi Hospital 600
Early research (Phase 1)Ended earlyNCT01457131
What this trial is testing

Modified White Blood Cells That Secrete IL-2 and Express a Protein That Targets the ESO-1tumor Protein for Metastatic Cancer

Who this might be right for
Metastatic CancerMetastatic MelanomaMetastatic Renal Cancer
National Cancer Institute (NCI) 2
Early research (Phase 1)Study completedNCT01453283
What this trial is testing

Tabectedin to Treat Children and Adolescents With Cancer

Who this might be right for
Solid Tumors
National Cancer Institute (NCI) 12
Not applicableStudy completedNCT01173445
What this trial is testing

Circulating Tumors Cells and Circulating Endothelial Cells in Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
University of Kansas 19
Not applicableStudy completedNCT01367457
What this trial is testing

INHIBITOR: Retrospective Study Of Patients With Renal Cell Carcinoma And Mantle Cell Lymphoma Treated With Temsirolimus

Who this might be right for
Carcinoma, Renal CellLymphoma, Mantle-Cell
Pfizer 243
Very early researchStudy completedNCT03473730
What this trial is testing

Daratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer

Who this might be right for
Bladder Urothelial CarcinomaClear Cell Renal Cell CarcinomaMalignant Urinary System Neoplasm+2 more
M.D. Anderson Cancer Center 17
Not applicableEnded earlyNCT03134027
What this trial is testing

Reconstitution of a Human Immune System in a Patient Derived Xenograft (PDX) Model of Genitourinary (GU) Cancers

Who this might be right for
Genito Urinary CancerBladder CancerKidney Cancer+1 more
Duke University 3
Large-scale testing (Phase 3)Study completedNCT00720941
What this trial is testing

Pazopanib Versus Sunitinib in the Treatment of Locally Advanced and/or Metastatic Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Novartis Pharmaceuticals 1,110
Early research (Phase 1)Study completedNCT00001683
What this trial is testing

A Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic Cancer

Who this might be right for
LymphomaMelanomaNeoplasm Metastasis+1 more
National Cancer Institute (NCI) 35
Not applicableStudy completedNCT01339962
What this trial is testing

Retrospective Analysis Of Progression Free Survival And Overall Survival In A National Cohort Of Patients With Metastatic Renal Cell Carcinoma Treated In Denmark From 2006-2010. DARENCA Study 2.

Who this might be right for
Renal Cell Carcinoma
Pfizer 1,073
Not applicableStudy completedNCT04222374
What this trial is testing

Uro-DNA Collection for Expanded Genome-Wide Association Study (GWAS) of Renal Cell Carcinoma (RCC)

Who this might be right for
Kidney Cancer
University Hospital, Bordeaux 200
Testing effectiveness (Phase 2)Study completedNCT00027820
What this trial is testing

Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionChildhood Acute Lymphoblastic Leukemia in RemissionChildhood Acute Myeloid Leukemia in Remission+27 more
Fred Hutchinson Cancer Center 106
Large-scale testing (Phase 3)Study completedNCT00291369
What this trial is testing

Cytokines in Patients With Metastatic Renal Cell Carcinoma of Intermediate Prognosis

Who this might be right for
Metastatic Renal Cell Carcinoma
Centre Leon Berard 456
Not applicableLooking for participantsNCT06967961
What this trial is testing

Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers

Who this might be right for
Urothelial CarcinomaRenal CancerProstate Adenocarcinoma+7 more
Institut Claudius Regaud 450
Testing effectiveness (Phase 2)UnknownNCT00024388
What this trial is testing

Chemotherapy in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Theradex
Not applicableUnknownNCT05243173
What this trial is testing

Biomarkers of Response to Systemic Treatments in FH-deficient RCC

Who this might be right for
MetabolomicsRenal Cell CarcinomaFH-Deficient RCC+1 more
RenJi Hospital 100
Not applicableLooking for participantsNCT07301827
What this trial is testing

Study on the Diagnostic Value of Novel PET Molecular Imaging for Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 66
Next Page